Managing Different MIGS Patients

Managing Different MIGS Patients
Media formats available:
Details
Presenters
  • Overview

    In this video interview, Drs. May, Autry, and Schweitzer discuss managing different MIGS patients. By the end of this class, you will learn the unique characteristics of different types of MIGS patients and how to effectively communicate with them.

    This activity is supported by an unrestricted educational grant from Sight Sciences.

  • Learning Objectives

    Upon completion of this activity, the participant should be able to:

    • Review the impact of patient compliance on conventional glaucoma treatment outcomes
    • Identify the importance of earlier intervention with the glaucoma patient, regardless of disease severity levels
    • Compare and contrast standalone and cataract MIGS patients: patient demographics, surgical procedure, and patient follow-up parameters
    • Describe the impact of resistance in different outflow pathways on glaucoma patient outcomes
    • Identify the efficacy levels, short-term complication rates, and long-term tissue removal risks of various glaucoma surgical procedures
    • Understand the MIGS patient journey: How to identify ideal MIGS patients, educate and set expectations, and manage these patients postoperatively
    • Accreditation

      Sponsored by:  

      Evolve Medical Education LLC (Evolve) is a COPE-accredited administrator. 

      This activity, COPE Activity Number 124320, is accredited by COPE for continuing education for optometrists for 0.25 hours.

      Course #: 79156-GL
      Activity #: 124320

      COPE advises optometrists to contact the State or Provincial Board where they are licensed for verification of what is acceptable for license renewal.

    • Participation Method

      In order to obtain credit, proceed through the program, complete the post-test, evaluation and submit for credit.

    • Faculty and Disclosures

      Kristopher A. May, OD, FAAO

      Kristopher A. May, OD, FAAO

      Owner, Coldwater Vision Center 
      Coldwater, Ashland, and Tishomingo, MS 
      Part-time and Adjunct Faculty 
      Southern College of Optometry 
      Memphis, TN 


      Jill C. Autry OD, RPh

      Jill C. Autry OD, RPh

      Partner, Eye Center of Texas
      Houston, TX


      Justin Schweitzer, OD, FAAO

      Justin Schweitzer, OD, FAAO

      Vance Thompson Vision
      Sioux Falls, SD


      DISCLOSURE POLICY
      It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent financial relationships relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all financial relationships prior to this educational activity.

      The following faculty/staff members have the following financial relationships with ineligible companies.

      Kristopher A. May, OD, FAAO, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Alcon and Sight Sciences. Speaker’s Bureau: Alcon, Bausch + Lomb, and Sight Sciences.

      Jill C. Autry OD, RPh, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Allergan and Ivantis. Speaker's Bureau: Ivantis.

      Justin Schweitzer, OD, FAAO, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Aerie Pharmaceuticals, Alcon, Allergan, Bausch + Lomb, Carl Zeiss Meditec, Dompé, Glaukos, LKC, MediPrint, Ocular Therapeutix, Quidel, Sight Sciences, Sun Pharmaceutical Industries, Reichert, and Visus. Grant/Research Support: Glaukos. Speaker's Bureau: Aerie Pharmaceuticals, Alcon, Allergan, Bausch + Lomb, Carl Zeiss Meditec, Glaukos, LKC, Sight Sciences, and Sun Pharmaceutical Industries. Stock/Shareholder: Equinox.

      The Evolve and The Fundingsland Group staff, planners, and reviewers have no financial relationships with ineligible companies.

    • Disclaimer

      OFF-LABEL STATEMENT
      This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

      DISCLAIMER
      The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve, The Fundingsland Group, or Sight Sciences.

    • System Requirements

      • Supported Browsers (2 most recent versions):
        • Google Chrome for Windows, Mac OS, iOS, and Android
        • Apple Safari for Mac OS and iOS
        • Mozilla Firefox for Windows, Mac OS, iOS, and Android
        • Microsoft Edge for Windows
      • Recommended Internet Speed: 5Mbps+

    • Publication Dates

      Release Date:

      Expiration Date:

    Ready to Claim Your Credits?

    You have attempts to pass this post-test. Take your time and review carefully before submitting.

    Good luck!

    Register

    We're glad to see you're enjoying Evolve Medical Education…
    but how about a more personalized experience?

    Register for free